Cargando…
Quality Control Optimization for Minimizing Security Risks Associated with Mesenchymal Stromal Cell-Based Product Development
Mesenchymal stromal cells (MSCs) have been considered a therapeutic strategy in regenerative medicine because of their regenerative and immunomodulatory properties. The translation of MSC-based products has some challenges, such as regulatory and scientific issues. Quality control should be standard...
Autores principales: | Rebelatto, Carmen Lúcia Kuniyoshi, Boldrini-Leite, Lidiane Maria, Daga, Debora Regina, Marsaro, Daniela Boscaro, Vaz, Isadora May, Jamur, Valderez Ravaglio, de Aguiar, Alessandra Melo, Vieira, Thalita Bastida, Furman, Bianca Polak, Aguiar, Cecília Oliveira, Brofman, Paulo Roberto Slud |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10455270/ https://www.ncbi.nlm.nih.gov/pubmed/37629136 http://dx.doi.org/10.3390/ijms241612955 |
Ejemplares similares
-
Combined Use of Tocilizumab and Mesenchymal Stromal Cells in the Treatment of Severe Covid-19: Case Report
por: Senegaglia, Alexandra Cristina, et al.
Publicado: (2021) -
Expanded CD133(+) Cells from Human Umbilical Cord Blood Improved Heart Function in Rats after Severe Myocardial Infarction
por: Correa, Alejandro, et al.
Publicado: (2018) -
Safety and long-term improvement of mesenchymal stromal cell infusion in critically COVID-19 patients: a randomized clinical trial
por: Rebelatto, Carmen Lúcia Kuniyoshi, et al.
Publicado: (2022) -
Genetic evaluation of mesenchymal stem cells by G-banded karyotyping in a Cell Technology Center
por: Borgonovo, Tamara, et al.
Publicado: (2014) -
Emergence of clonal chromosomal alterations during the mesenchymal stromal cell cultivation
por: Borgonovo, Tamara, et al.
Publicado: (2015)